Selenium and Ischemic Stroke Outcome

Not yet recruiting

Phase 0 Results N/A

Summary of Purpose

Selenium is a trace element essential to human health.Selenium protection against cellular damage by oxygen radicals is accomplished through selenoproteins. Ischemic stroke is associated with the generation of oxygen free radicals resulting in a condition of oxidative stress. Supplementing stroke patients with antioxidant nutrients may improve survival.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 July 2015.

1 Jul 2015 11 Jul 2015 1 Dec 2015 1 Jul 2016 1 Jul 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


  • athena sharifi razavi, MD